Drawing for VAPOURSOFT

USPTO serial 79302420

VAPOURSOFT

Reviewed by CopyMark Law Group

Reg. 6951809Status 700Registered
Filing date
Status date
Registration date
Jan 17, 2023
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VAPOURSOFT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Hydrofluoroalkanes (HFA) powered and liquefied gas powered apparatus and instruments for use in or in relation to drug and pharmaceutical delivery devices, namely, hydrofluoroalkanes (HFA) powered drug delivery systems in the nature of infusion and injection devices for administering drugs; hydrofluoralkanes (HFA) powered medical syringes, medical fluid auto-injectors for administering pharmaceuticals and drugs and apparatus and devices for the inhalation or injection of pharmaceuticals and drugs, namely, injection needles, medical fluid auto-injectors and syringes; hydrofluoralkanes (HFA) powered catheters, transfusion sets and injection syringes for administering drugs and pharmaceuticals, and also incorporating audio, visual and/or tactile patient feedback mechanisms relating to drug and pharmaceutical delivery dosage, measuring and monitoring information; hydrofluoralkanes (HFA) powered medical syringes, medical fluid auto-injectors, drug delivery systems comprised of implantable drug delivery ports incorporating audio, visual and/or tactile patient feedback mechanisms to convey dosage, measuring, and monitoring data for the purpose of facilitating and monitoring drug and pharmaceutical delivery and administration; medical syringes; medical syringe stoppers; hydrofluoroolefin (HFO) powered medical fluid auto-injectors and medical fluid injectors; hydrofluoroolefin (HFO) powered apparatus and devices for administering pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, and hypodermic needles; hydrofluoroolefin (HFO) powered drug delivery apparatus, namely, drug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes; apparatus and devices for administering pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, and hypodermic needles; sterile medical syringes and medical fluid auto-injectors for the administration of pharmaceuticals and drugs; cartridges sold empty and specially adapted for medical syringes; nozzles sold empty and specially adapted for medical syringes; drug delivery apparatus, namely, drug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; oral and nasal medication dispensers, namely, aerosol dispensers for medical use; aerosol dispensers for medical purposes; structural replacement parts and fittings for all the aforesaid goodsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 29, 2024RNWLINTERNATIONAL REGISTRATION RENEWED
May 16, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 26, 2023FIMPFINAL DISPOSITION PROCESSED
Apr 17, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 17, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 22, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2022GPNXNOTIFICATION PROCESSED BY IB
Oct 12, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 12, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2022RFNTREFUSAL PROCESSED BY IB
Mar 9, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2022ATRVATTORNEY REVIEW COMPLETED
Jan 12, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Dec 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Jul 18, 2021RFNTREFUSAL PROCESSED BY IB
Jun 21, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 21, 2021RFRRREFUSAL PROCESSED BY MPU
Jun 12, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2021DOCKASSIGNED TO EXAMINER
Jan 23, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 19, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance